We define penny stocks as shares trading under $5.00, which usually fall into the small cap category.
Keep Reading →
April 21 - Hedge Funds, News
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2024 Earnings Call Transcript February 27, 2025AbCellera Biologics Inc. beats earnings expectations.
Keep Reading →
February 28 - News, Transcripts
We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL.
Keep Reading →
January 17 - News, Stock Analysis
According to a report by the Government of Canada, released on December 16, the country's economic outlook has been revised upward, as private-sector economists forecast moderate...
Keep Reading →
January 6 - Hedge Funds, News
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript November 4, 2024AbCellera Biologics Inc. misses on earnings expectations.
Keep Reading →
November 5 - News, Transcripts
The Federal Reserve slashed interest rates by a half point in September, kickstarting its first easing campaign in four years.
Keep Reading →
October 8 - Hedge Funds, News
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor...
Keep Reading →
August 29 - Hedge Funds, News
As we navigate the complexities of 2024, Canada's economic landscape presents a unique blend of challenges and opportunities.
Keep Reading →
August 27 - Hedge Funds, News
Operator: Good afternoon. And welcome to AbCellera’s Q2 2024 Business Update Conference Call.
Keep Reading →
August 7 - News, Transcripts
Operator: Good afternoon and welcome to AbCellera's Q1, 2024 Business Update Conference Call.
Keep Reading →
May 8 - News, Transcripts
In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read...
Keep Reading →
March 26 - Hedge Funds, Insider Trading, News
AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc.
Keep Reading →
February 21 - News, Transcripts
In this article, we will take a detailed look at the 16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy ...
Keep Reading →
December 11 - Hedge Funds, News
In this piece, we will take a look at billionaire Druckenmiller's 5 stocks picks with huge upside potential. If you want to read our introduction to Mr.
Keep Reading →
December 8 - Hedge Funds, News
Operator: Good afternoon, and welcome to AbCellera's Third Quarter 2023 Business Update Conference Call.
Keep Reading →
November 3 - News, Transcripts
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Keep Reading →
September 29 - Hedge Funds, News
In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout.
Keep Reading →
August 31 - News, Quantitative Investing
In this article, we will be taking a look at 10 stocks that could 10x over the next 10 years.
Keep Reading →
August 31 - Hedge Funds, News
In this piece, we will take a look at billionaire Stanley Druckenmiller's small-cap stock picks. If you want to skip our introduction to Mr.
Keep Reading →
August 19 - Hedge Funds, News
Operator: Good afternoon, and thank you, and welcome to AbCellera's Second Quarter 2023 Business Update Conference Call.
Keep Reading →
August 4 - News, Transcripts
In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.
Keep Reading →
July 28 - News
In this article, we discuss 10 best Canadian stocks under $10.
Keep Reading →
July 26 - Hedge Funds, News
Operator: Good afternoon. And welcome to AbCellera's First Quarter 2023 Business Update Conference Call.
Keep Reading →
May 5 - News, Transcripts
Operator: Good afternoon. And welcome to AbCellera's Full-Year 2022 Business Update Conference Call.
Keep Reading →
February 23 - News, Transcripts
In this article, we will take a look at the 5 most undervalued biotech stocks to buy according to hedge funds.
Keep Reading →
February 14 - Hedge Funds, News
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotech company. AbCellera Biologics Inc. (NASDAQ:ABCL) is operating in the human antibodies space.
Keep Reading →
January 21 - Hedge Funds, News
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian company that is operating in the domain of human antibodies.
Keep Reading →
January 10 - Hedge Funds, News
Operator: Good afternoon. And welcome to AbCellera's Third Quarter 2022 Business Update Conference Call.
Keep Reading →
December 30 - News, Transcripts
AbCellera Biologics Inc.
Keep Reading →
December 12 - Hedge Funds, News
In this article, we discuss the top 5 picks of the Harvard University stock portfolio.
Keep Reading →
November 2 - Hedge Funds, News
Stocks have been sandwiched between inflation and an aggressive Fed.
Keep Reading →
October 25 - Hedge Funds, News
In this article, we discuss the 11 cheap healthcare stocks to invest in.
Keep Reading →
October 5 - Hedge Funds, News
In this article, we will look at the 10 best biotech stocks under $10.
Keep Reading →
September 26 - Hedge Funds, News
In this article, we will look at Harvard University's latest stock portfolio and list its 5 best biotech stock picks.
Keep Reading →
September 15 - Hedge Funds, News
In this article, we discuss the 9 stocks Masayoshi Son is selling in 2022.
Keep Reading →
May 25 - Hedge Funds, News
In this article, we discuss the 5 stocks to watch from the 2022 portfolio of Korean-Japanese Billionaire Masayoshi Son.
Keep Reading →
May 24 - Hedge Funds, News
In this article, we discuss 5 value stock picks of billionaire Stanley Druckenmiller in 2022.
Keep Reading →
May 19 - Hedge Funds, News
In this piece, we will take a look at the five healthcare stocks to invest in today according to Stanley Druckenmiller.
Keep Reading →
April 21 - Hedge Funds, News
Below is the list of top 5 stock picks of billionaire Masayoshi Son.
Keep Reading →
March 20 - Hedge Funds, News
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
January 12 - Hedge Funds, News
In this piece, we will take a look at Japanese billionaire Masayoshi Son's investments: Top 5 stock picks. If you want to take a detailed look at Mr.
Keep Reading →
November 26 - Hedge Funds, News
In this article, we discuss the 10 new stock picks of billionaire Stanley Druckenmiller.
Keep Reading →
November 19 - Hedge Funds, News
Renaissance Technologies quadrupled its Tesla stake and boosted its AMC Entertainment bet by nearly 40% in the third quarter, Securities and Exchange Commission filings show.
Keep Reading →
November 15 - Hedge Funds, Insider Trading
In this article, we discuss the top 10 picks in Harvard University's stock portfolio.
Keep Reading →
October 11 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
July 21 - Hedge Funds, News
AbCellera Biologics Inc. (NASDAQ:ABCL) was founded by Carl Hansen and his fellow researchers in 2012.
Keep Reading →
April 27 - Earnings Report, News
In this article we will analyze whether AbCellera Biologics Inc.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we examined Billionaire Masayoshi Son's investment strategy that helped him in generating billions of dollars in profits last year.
Keep Reading →
March 16 - Hedge Funds, News
In this article we talk about 15 fastest growing biotech companies in the US.
Keep Reading →
February 27 - Lists, News